Inventor · disambiguated record
Jonathan Back
Also filed as: BACK JONATHAN · BACK JONATHAN ALBERT
19 granted patents·16 pending applications·402 citations·filing 2005–2025
95Inventor score
Files withIchnos Sciences SA10ELECTRONIC ARTS INC7ZEUGMA SYSTEMS INC7GLENMARK PHARMACEUTICALS SA5GLYCOERA AG2
Top patents by PatentIndex Score
35 records- 0197US7773510B2Application routing in a distributed compute environmentZEUGMA SYSTEMS INC·Filed 2007·Granted Aug 10, 2010·97 cites·34 claims
- 0297US7706291B2Monitoring quality of experience on a per subscriber, per session basisZEUGMA SYSTEMS INC·Filed 2007·Granted Apr 27, 2010·74 cites·27 claims
- 0396US7508764B2Packet flow bifurcation and analysisZEUGMA SYSTEMS INC·Filed 2005·Granted Mar 24, 2009·70 cites·30 claims
- 0493US8374102B2Intelligent collection and management of flow statisticsTELLABS COMM CANADA LTD·Filed 2007·Granted Feb 12, 2013·57 cites·28 claims
- 0592US9290576B2Antibodies that bind to TL1A and their usesGLENMARK PHARMACEUTICALS SA·Filed 2014·Granted Mar 22, 2016·22 cites·51 claims
- 0692US8748585B2Antibodies that bind to OX40 and their usesATTINGER ANTOINE·Filed 2012·Granted Jun 10, 2014·36 cites·68 claims
- 0791US10369460B1Systems and methods for generating a compilation reel in game videoELECTRONIC ARTS INC·Filed 2018·Granted Aug 6, 2019·7 cites·20 claims
- 0890US7620526B2Technique for accessing a database of serializable objects using field values corresponding to fields of an object marked with the same index valueZEUGMA SYSTEMS INC·Filed 2006·Granted Nov 17, 2009·19 cites·16 claims
- 0989US11773166B2CD3/CD38 T cell retargeting hetero-dimeric immunoglobulins and methods of their productionIchnos Sciences SA·Filed 2018·Granted Oct 3, 2023·5 cites·12 claims
- 1089US9950251B1Systems and methods for generating a compilation reel in game videoELECTRONIC ARTS INC·Filed 2017·Granted Apr 24, 2018·4 cites·20 claims
- 1182US11407839B2Antibodies that bind to OX40 and their usesIchnos Sciences SA·Filed 2019·Granted Aug 9, 2022·1 cites·30 claims
- 1281US12281169B2Antibodies that bind to OX40 and their usesIchnos Sciences SA·Filed 2022·Granted Apr 22, 2025·0 cites·28 claims
- 1377US7761485B2Distributed databaseZEUGMA SYSTEMS INC·Filed 2006·Granted Jul 20, 2010·10 cites·32 claims
- 1477US2025250351A1Antibodies that bind to ox40 and their usesIchnos Sciences SA·Filed 2025·Application pending·0 cites
- 1576US2025059290A1Anti-ox40 antagonistic antibodies for the treatment of autoimmune diseasesIchnos Sciences SA·Filed 2024·Application pending·0 cites
- 1672US12006367B2CD3/CD38 T cell retargeting hetero-dimeric immunoglobulins and methods of their productionIchnos Sciences SA·Filed 2022·Granted Jun 11, 2024·0 cites·9 claims
- 1766US2024059783A1Anti-ox40 antagonistic antibodies and dosage for the treatment of ox40-mediated disordersIchnos Sciences SA·Filed 2023·Application pending·0 cites
- 1864US10974130B1Systems and methods for indicating events in game videoELECTRONIC ARTS INC·Filed 2018·Granted Apr 13, 2021·0 cites·20 claims
- 1963US2021214453A1Anti-ox40 antagonistic antibodies for the treatment of autoimmune diseasesIchnos Sciences SA·Filed 2019·Application pending·0 cites
- 2062US10099116B1Systems and methods for indicating events in game videoELECTRONIC ARTS INC·Filed 2018·Granted Oct 16, 2018·0 cites·20 claims
- 2162US9776075B2Systems and methods for indicating events in game videoELECTRONIC ARTS INC·Filed 2014·Granted Oct 3, 2017·0 cites·21 claims
- 2262US9776076B2Systems and methods for generating a compilation reel in game videoELECTRONIC ARTS INC·Filed 2014·Granted Oct 3, 2017·0 cites·23 claims
- 2362US2014294824A1Antibodies that bind to ox40 and their usesGLENMARK PHARMACEUTICALS SA·Filed 2014·Application pending·0 cites
- 2461US9919204B1Systems and methods for indicating events in game videoELECTRONIC ARTS INC·Filed 2017·Granted Mar 20, 2018·0 cites·20 claims
- 2558US2010017416A1Serializable objects and a database thereofZEUGMA SYSTEMS INC·Filed 2009·Application pending·0 cites
- 2658US2017260280A1Antibodies that Bind to OX40 and Their UsesGLENMARK PHARMACEUTICALS SA·Filed 2016·Application pending·0 cites
- 2758US2010023552A1Serializable objects and a database thereofZEUGMA SYSTEMS INC·Filed 2009·Application pending·0 cites
- 2857US2020079863A1Antibodies that bind to tl1a and their usesGLENMARK PHARMACEUTICALS SA·Filed 2019·Application pending·0 cites
- 2956US2025281626A1Mannose 3 glycan-mediated protein degradationGLYCOERA AG·Filed 2022·Application pending·0 cites
- 3056US2025282886A1Glycan-mediated protein degradationGLYCOERA AG·Filed 2022·Application pending·0 cites
- 3155US2021206864A1Anti-ox40 antagonistic antibodies and dosage for the treatment of ox40-mediated disordersIchnos Sciences SA·Filed 2019·Application pending·0 cites
- 3251US2018086840A1Antibodies that bind to tl1a and their usesGLENMARK PHARMACEUTICALS SA·Filed 2017·Application pending·0 cites
- 3351US2024067714A1Fab sialylation of antibodiesLIMMATECH BIOLOGICS AG·Filed 2021·Application pending·0 cites
- 3445US2008298230A1Scheduling of workloads in a distributed compute environmentLUFT SIEGFRIED J·Filed 2007·Application pending·0 cites
- 3541US2020347143A1Novel tnfr agonists and uses thereofIchnos Sciences SA·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jonathan Back files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →